Raffles Medical Group
Price target:
RHB “neutral” $0.91
CGS-CIMB “hold” $0.96
OCBC “hold” $0.96
Maybank Kim Eng “neutral” $0.99

Analysts remain cautious due to continuing epidemic

Analysts are maintaining a cautious stance on Raffles Medical Group (RMG) following the announcement of its 1H2020 results on July 27.  In what RHB analyst Juliana Cai deems “results infected by Covid-19”, RMG posted a 38.2% drop in earnings to $17.2 million.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook